Eco R1 Capital, LLC Portfolio Holdings

Eco R1 Capital, LLC

  • $1.33 Billion
  • Q3 2025

Eco R1 Capital, LLC has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $1.33 Billion distributed in 30 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Uni Qure N.V. with a value of $233M, Jazz Pharmaceuticals PLC with a value of $225M, Crinetics Pharmaceuticals, Inc. with a value of $179M, Crispr Therapeutics Ag with a value of $90M, and Tango Therapeutics, Inc. with a value of $89.3M.

Examining the 13F form we can see an increase of $171M in the current position value, from $1.16B to 1.33B.

Eco R1 Capital, LLC is based out at San Francisco, CA

Below you can find more details about Eco R1 Capital, LLC portfolio as well as his latest detailed transactions.

Portfolio value $1.33 Billion
Healthcare: $1.32 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.4B
$233 Million 17.49% of portfolio
3,988,971
Q1 2025 Added 17.32%
$8.84B
$225 Million 16.89% of portfolio
1,706,469
Q3 2024 Added 68.3%
$2.34B
$179 Million 13.41% of portfolio
4,288,120
Q3 2024 Added 3.19%
$4.32B
$90 Million 6.76% of portfolio
1,389,276
Q1 2024 New
$720M
$89.3 Million 6.71% of portfolio
10,630,736
Q4 2024 Reduced 20.25%
$518M
$80.3 Million 6.03% of portfolio
6,728,116
Q3 2025 Added 315.81%
$2.23B
$78 Million 5.86% of portfolio
3,447,156
Q3 2025 Reduced 71.02%
$891M
$72.1 Million 5.41% of portfolio
6,144,767
Q4 2024 Added 15.28%
$2.06B
$57.7 Million 4.34% of portfolio
1,667,119
Q3 2025 Added 60.77%
$208M
$47.3 Million 3.55% of portfolio
4,079,415
Q1 2025 Added 5.16%
$428M
$44.3 Million 3.33% of portfolio
2,030,544
Q2 2025 Added 4.71%
$9.05B
$34.4 Million 2.58% of portfolio
75,000
Q1 2024 New
$3.69B
$33.3 Million 2.5% of portfolio
765,000
Q3 2025 Added 53.0%
$4.77B
$15 Million 1.13% of portfolio
500,000
Q2 2025 New
$288M
$14.7 Million 1.1% of portfolio
2,625,000
Q3 2025 New
$2.6B
$13.3 Million 1.0% of portfolio
550,000
Q3 2025 New
$749M
$7.72 Million 0.58% of portfolio
872,500
Q3 2025 Reduced 79.23%
$112M
$3.7 Million 0.28% of portfolio
800,000
Q3 2025 New
$155M
$3.1 Million 0.23% of portfolio
670,303
Q3 2025 Reduced 82.89%
$363M
$2.26 Million 0.17% of portfolio
265,137
Q3 2025 New
Anaptysbio Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 0.08%
Atara Biotherapeutics Inc
-
$0 0.0% of portfolio
-
Q1 2025 Added 7.71%
Bridgebio Oncology Therapeut
-
$0 0.0% of portfolio
-
Q3 2025 New
$0
$1,000 0.0% of portfolio
66,665
Q3 2021 New
Mbx Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 84.69%
-
$0 0.0% of portfolio
-
Q1 2021 New
Neurogene Inc
-
$0 0.0% of portfolio
-
Q4 2023 New
Metsera Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 443.06%
Zymeworks Inc
-
$0 0.0% of portfolio
-
Q2 2025 Added 33.09%

Summary

  • Portfolio
  • No. of Stocks 30
  • Current Value $1.33 Billion
  • Prior Value $1.16 Billion
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 6 stocks
  • Additional Purchases 4 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Eco R1 Capital, LLC Portfolio

Follow Eco R1 Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email